Terms: = Liver cancer AND MYCL, LMYC, 4610, MYCL1, ENSG00000116990 AND Treatment
4 results:
1. Direct Conversion of Human Endothelial Cells Into liver cancer-Forming Cells Using Nonintegrative Episomal Vectors.
Goya T; Horisawa K; Udono M; Ohkawa Y; Ogawa Y; Sekiya S; Suzuki A
Hepatol Commun; 2022 Jul; 6(7):1725-1740. PubMed ID: 35220676
[TBL] [Abstract] [Full Text] [Related]
2. Comprehensive serial molecular profiling of an "N of 1" exceptional non-responder with metastatic prostate cancer progressing to small cell carcinoma on treatment.
Kadakia KC; Tomlins SA; Sanghvi SK; Cani AK; Omata K; Hovelson DH; Liu CJ; Cooney KA
J Hematol Oncol; 2015 Oct; 8():109. PubMed ID: 26444865
[TBL] [Abstract] [Full Text] [Related]
3. Survival outcomes in patients with advanced hepatocellular carcinoma treated with drug-eluting bead chemoembolization.
Ray CE; Brown AC; Green TJ; Winston H; Curran C; Kreidler SM; Glueck DH; Rochon PJ
AJR Am J Roentgenol; 2015 Feb; 204(2):440-7. PubMed ID: 25615768
[TBL] [Abstract] [Full Text] [Related]
4. AKR1B10 induces cell resistance to daunorubicin and idarubicin by reducing C13 ketonic group.
Zhong L; Shen H; Huang C; Jing H; Cao D
Toxicol Appl Pharmacol; 2011 Aug; 255(1):40-7. PubMed ID: 21640744
[TBL] [Abstract] [Full Text] [Related]
